Plasma-activated thermosensitive biogel as an exogenous ROS carrier for post-surgical treatment of cancer.
Plasma-activated biogel
Post-operative tumor treatment
Reactive oxygen species
Surface discharge plasma
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
23
03
2021
revised:
14
07
2021
accepted:
04
08
2021
pubmed:
17
8
2021
medline:
21
9
2021
entrez:
16
8
2021
Statut:
ppublish
Résumé
Post-surgical residual tumor cells are the primary cause of relapse and progression of cancer but unfortunately, there are limited therapeutic options. In this work, a fillable plasma-activated biogel is produced on a thermosensitive biogel [(Poly-DL-lactide)-(poly-ethylene glycol)-(poly-DL-lactide), PLEL] with the aid of a discharge plasma for local post-operative treatment of cancer. In vivo data show that the plasma-activated PLEL biogel (PAPB) eliminates residual tumor tissues after removal surgery and also inhibits in situ recurrence while showing no evident systemic toxicity. Moreover, the PAPB possesses excellent storage capability, allows for slow release of plasma-generated reactive oxygen species (ROS), and exhibits good ROS-mediated anticancer effects in vitro. Our results reveal that the novel plasma-activated biogel is an effective therapeutic agent for local post-operative treatment of cancer.
Identifiants
pubmed: 34399120
pii: S0142-9612(21)00413-0
doi: 10.1016/j.biomaterials.2021.121057
pii:
doi:
Substances chimiques
Hydrogels
0
Reactive Oxygen Species
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
121057Informations de copyright
Copyright © 2021 Elsevier Ltd. All rights reserved.